Literature DB >> 16205304

Management of Chlamydia cases and their partners: results from a home-based screening program organized by municipal public health services with referral to regular health care.

Hannelore M Götz1, Christian J P A Hoebe, Jan E A M Van Bergen, Irene K Veldhuijzen, Jan Broer, F De Groot, M J C Verhooren, D T Van Schaik, A J J Coenen, Jan H Richardus.   

Abstract

BACKGROUND: We evaluated the management of Chlamydia trachomatis cases and partners found in a systematic home-based chlamydia screening project in the Netherlands among 15- to 29-year-old women and men, organized by the Municipal Public Health Services (MHS).
METHODS: Infected participants (165/8339 = 2%) were referred to regular curative services. The treating physician provided feedback on treatment and partner notification.
RESULTS: Including the effect of a reminder, the treatment rate of all index cases was 91% (150/165); among persons with non-Dutch ethnicity, 81% (25/31). The majority of cases (82%) consulted the general practitioner for treatment as opposed to sexually transmitted disease/MHS clinics (18%). Eighty-five percent of cases were treated within 2 weeks. The confirmed treatment rate of partners in the last 6 months was 49% (86/176); 57% (81/141) for current versus 14% (5/35) for other partners. Patient referral was advised in an additional 18% (25/141) of current partners and in 9% (3/35) of other partners (potential treatment).
CONCLUSION: Home-based chlamydia screening and treatment through regular treatment facilities has proven to be effective in the Netherlands. The necessity of a reminder to increase treatment rate and the lower treatment rate in non-Dutch high-risk groups deserve attention. Low confirmed treatment rate of current partners carries the potential of reinfection, and patient-delivered treatment should be expanded.

Entities:  

Mesh:

Year:  2005        PMID: 16205304     DOI: 10.1097/01.olq.0000175397.82962.d5

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  4 in total

1.  Assessing non-response to a mailed health survey including self-collection of biological material.

Authors:  Anneli Uusküla; Mart Kals; Louise-Anne McNutt
Journal:  Eur J Public Health       Date:  2010-05-10       Impact factor: 3.367

2.  Prevalence of cases of Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum and Chlamydia trachomatis in women with no gynecologic complaints.

Authors:  Denise Maria Christofolini; Luciana Leuzzi; Fernanda Abani Mafra; Itatiana Rodart; Erika Azuma Kayaki; Bianca Bianco; Caio Parente Barbosa
Journal:  Reprod Med Biol       Date:  2012-07-11

3.  Rationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands.

Authors:  Jan E A M van Bergen; Johannes S A Fennema; Ingrid V F van den Broek; Elfi E H G Brouwers; Eva M de Feijter; Christian J P A Hoebe; Rik H Koekenbier; Eline L M Op de Coul; Sander M van Ravesteijn; Hannelore M Götz
Journal:  BMC Infect Dis       Date:  2010-10-07       Impact factor: 3.090

Review 4.  Home-based chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes.

Authors:  Muhammad S Jamil; Jane S Hocking; Heidi M Bauer; Hammad Ali; Handan Wand; Kirsty Smith; Jennifer Walker; Basil Donovan; John M Kaldor; Rebecca J Guy
Journal:  BMC Public Health       Date:  2013-03-04       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.